U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C30H29ClN6O4
Molecular Weight 573.042
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of NERATINIB DIMETHYLAMINE N-OXIDE

SMILES

CCOC1=C(NC(=O)\C=C\C[N+](C)(C)[O-])C=C2C(=C1)N=CC(C#N)=C2NC3=CC(Cl)=C(OCC4=NC=CC=C4)C=C3

InChI

InChIKey=DREVEVQWSRJACN-VQHVLOKHSA-N
InChI=1S/C30H29ClN6O4/c1-4-40-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2,3)39)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)41-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+

HIDE SMILES / InChI

Molecular Formula C30H29ClN6O4
Molecular Weight 573.042
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 15:48:34 GMT 2023
Edited
by admin
on Sat Dec 16 15:48:34 GMT 2023
Record UNII
QUH15J9Q1Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NERATINIB DIMETHYLAMINE N-OXIDE
Common Name English
HKI-272 DIMETHYLAMINE N-OXIDE
Code English
NERATINIB METABOLITE M7
Common Name English
WYE-121592
Code English
2-BUTENAMIDE, N-(4-((3-CHLORO-4-(2-PYRIDINYLMETHOXY)PHENYL)AMINO)-3-CYANO-7-ETHOXY-6-QUINOLINYL)-4-(DIMETHYLOXIDOAMINO)-, (2E)-
Systematic Name English
Code System Code Type Description
FDA UNII
QUH15J9Q1Q
Created by admin on Sat Dec 16 15:48:34 GMT 2023 , Edited by admin on Sat Dec 16 15:48:34 GMT 2023
PRIMARY
PUBCHEM
87687267
Created by admin on Sat Dec 16 15:48:34 GMT 2023 , Edited by admin on Sat Dec 16 15:48:34 GMT 2023
PRIMARY
CAS
1376615-55-2
Created by admin on Sat Dec 16 15:48:34 GMT 2023 , Edited by admin on Sat Dec 16 15:48:34 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Reference: NERATINIB IC50 = 17 nM
INHIBITOR
IC50
TARGET -> INHIBITOR
Reference: NERATINIB IC50 = 2.7 nM
INHIBITOR
IC50
TARGET -> INHIBITOR
NERATINIB was not evaluated.
INHIBITOR
IC50
Related Record Type Details
PARENT -> METABOLITE LESS ACTIVE
IC50 for HER2 kinase activity was up to 19 fold higher when compared to neratinib.
INHIBITOR
IC50